Mou CY - Search Results

1

Left ventricular opacification after peripheral venous injection of a modified albumin solution.

Lin SL, Lo JH, Mou CY, Ho SJ, Liu RH, Chan JY, Chang MS, Chiang HT, Chen CY. Lin SL, et al. Among authors: mou cy. Int J Card Imaging. 1992;8(1):53-61. doi: 10.1007/BF01137566. Int J Card Imaging. 1992. PMID: 1619305

2

Long-term prognosis of patients with obstructing carcinoma of the right colon.

Wang HS, Lin JK, Mou CY, Lin TC, Chen WS, Jiang JK, Yang SH. Wang HS, et al. Among authors: mou cy. Am J Surg. 2004 Apr;187(4):497-500. doi: 10.1016/j.amjsurg.2003.12.028. Am J Surg. 2004. PMID: 15041498

3

Mechanical unfolding and refolding of proteins: an off-lattice model study.

Li FY, Yuan JM, Mou CY. Li FY, et al. Among authors: mou cy. Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Feb;63(2 Pt 1):021905. doi: 10.1103/PhysRevE.63.021905. Epub 2001 Jan 19. Phys Rev E Stat Nonlin Soft Matter Phys. 2001. PMID: 11308516

4

No difference in the functional improvements between unilateral and bilateral total knee replacements.

Huang YH, Lin C, Yang JH, Lin LC, Mou CY, Chiang KT, Lee MG, Chang HF, Chang HL, Su W, Yeh SJ, Chang H, Wang CC, Su SL. Huang YH, et al. Among authors: mou cy. BMC Musculoskelet Disord. 2018 Mar 21;19(1):87. doi: 10.1186/s12891-018-2006-x. BMC Musculoskelet Disord. 2018. PMID: 29562893 Free PMC article. Clinical Trial.

5

Drug-Free Mesoporous Silica Nanoparticles Enable Suppression of Cancer Metastasis and Confer Survival Advantages to Mice with Tumor Xenografts.

Lee YT, Wu SH, Wu CH, Lin YH, Lin CK, Chen ZA, Sun TC, Chen YJ, Chen P, Mou CY, Chen YP. Lee YT, et al. Among authors: mou cy. ACS Appl Mater Interfaces. 2024 Nov 13;16(45):61787-61804. doi: 10.1021/acsami.4c16609. Epub 2024 Oct 24. ACS Appl Mater Interfaces. 2024. PMID: 39448366 Free PMC article.

6

Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication.

Liu CH, Pan YC, Lim SK, Mou CY, Hu CJ, Mou KY. Liu CH, et al. Among authors: mou cy. Cell Rep Med. 2024 Oct 15:101793. doi: 10.1016/j.xcrm.2024.101793. Online ahead of print. Cell Rep Med. 2024. PMID: 39442515 Free article.

7

High-Affinity Superantigen-Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression.

Yu YA, Lien WJ, Lin WC, Pan YC, Huang SW, Mou CY, Hu CJ, Mou KY. Yu YA, et al. Among authors: mou cy. Adv Sci (Weinh). 2024 Sep;11(33):e2310204. doi: 10.1002/advs.202310204. Epub 2024 Jun 27. Adv Sci (Weinh). 2024. PMID: 38937984 Free PMC article.

8

Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy.

Huang SW, Lim SK, Yu YA, Pan YC, Lien WJ, Mou CY, Hu CJ, Mou KY. Huang SW, et al. Among authors: mou cy. Elife. 2024 May 15;12:RP90798. doi: 10.7554/eLife.90798. Elife. 2024. PMID: 38747577 Free PMC article.

9

Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier.

Chen ZA, Wu CH, Wu SH, Huang CY, Mou CY, Wei KC, Yen Y, Chien IT, Runa S, Chen YP, Chen P. Chen ZA, et al. Among authors: mou cy. ACS Nano. 2024 May 21;18(20):12716-12736. doi: 10.1021/acsnano.3c08993. Epub 2024 May 8. ACS Nano. 2024. PMID: 38718220 Free PMC article.

10

Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.

Hsu TI, Chen YP, Zhang RL, Chen ZA, Wu CH, Chang WC, Mou CY, Chan HW, Wu SH. Hsu TI, et al. Among authors: mou cy. ACS Appl Mater Interfaces. 2024 May 1;16(17):21722-21735. doi: 10.1021/acsami.4c04289. Epub 2024 Apr 17. ACS Appl Mater Interfaces. 2024. PMID: 38629735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters